Sodium hydride → (R)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl 4-(4-trifluoromethylphenoxy)piperidine-1-carboxylate
반응식
[F:1][C:2]([F:34])([F:33])[C:3]1[CH:32]=[CH:31][C:6]([O:7][CH:8]2[CH2:13][CH2:12][N:11]([C:14]([O:16][CH2:17][C@@:18]([OH:30])([CH3:29])[CH2:19][N:20]3[CH:24]=[C:23]([N+:25]([O-:27])=[O:26])[N:22]=[C:21]3Cl)=[O:15])[CH2:10][CH2:9]2)=[CH:5][CH:4]=1.[H-].[Na+]>CN(C=O)C>[F:1][C:2]([F:34])([F:33])[C:3]1[CH:32]=[CH:31][C:6]([O:7][CH:8]2[CH2:13][CH2:12][N:11]([C:14]([O:16][CH2:17][C@:18]3([CH3:29])[O:30][C:21]4=[N:22][C:23]([N+:25]([O-:27])=[O:26])=[CH:24][N:20]4[CH2:19]3)=[O:15])[CH2:10][CH2:9]2)=[CH:5][CH:4]=1참가 물질
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
To the solution of (R)-3-(2-chloro-4-nitroimidazol-1-yl)-2-hydroxy-2-methylpropyl 4-(4-trifluoromethylphenoxy)piperidine-1-carboxylate prepared in Example 104 (0.18 g, 0.36 mmol) in DMF (2 ml), sodium hydride (19 mg, 0.47 mmol) was added followed by stirring for 1.5 hours with cooling on ice-bath. To the reaction mixture, ice-water was added, and the solution was extracted with ethyl acetate. The organic phase was washed with water, dried over magnesium sulfate and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (methylene chloride/ethyl acetate=9/1) and recrystallized from isopropanol to afford (R)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl 4-(4-trifluoromethylphenoxy)piperidine-1-carboxylate (0.08 g, yield 47%) as a white solid.
후처리
- temperaturewith cooling on ice-bath
- extractionthe solution was extracted with ethyl acetate
- washThe organic phase was washed with water
- dry with materialdried over magnesium sulfate
- concentrationconcentrated under reduced pressure
- customThe residue was purified by silica gel column chromatography (methylene chloride/ethyl acetate=9/1)
- customrecrystallized from isopropanol
출처 및 근거
- ORD 기록
- ord-663684a4030f4d649487c571af0faa2e
- 출처 데이터셋
- uspto-grants-2007_08
- 특허 번호
- US07262212B2
반응 노트
불러오는 중…